Search

everythinglearnresearchcommunity

for

Search:↓

Piptadeniastrum africanum and Cordia plathytyrsa can increase testosterone without major metabolic changes, but may affect triglycerides and creatinine.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Testosterone's muscle-building effects do not require its conversion to DHT.

DHT may increase the risk of heart disease and death in elderly men.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

DHT deficiency can disrupt cell connections in rat testes, possibly affecting fertility.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Different skin cells process testosterone differently, and certain drugs can change this process, possibly helping treat acne and hair loss.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Testosterone helps human pancreatic cells increase insulin release.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.